Hennion & Walsh Asset Management, Inc. Regenxbio Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

$2.06 Billion
Q3 2024

A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Regenxbio Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 151,715 shares of RGNX stock, worth $1.54 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

151,715

Previous 134,190 13.06%

Holding current value

$1.54 Million

Previous $1.57 Million 1.34%

% of portfolio

0.08%

Previous 0.08%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$10.49 - $14.39 $183,837 - $252,184	17,525 Added 13.06%	151,715 $1.59 Million
Q2 2024 Jul 19, 2024	BUY	$11.51 - $21.53 $321,198 - $600,816	27,906 Added 26.26%	134,190 $1.57 Million
Q1 2024 Apr 17, 2024	BUY	$12.17 - $24.61 $396,547 - $801,892	32,584 Added 44.21%	106,284 $2.24 Million
Q4 2023 Jan 10, 2024	BUY	$12.89 - $20.82 $171,901 - $277,655	13,336 Added 22.09%	73,700 $1.32 Million
Q3 2023 Oct 27, 2023	SELL	$16.46 - $19.99 $89,295 - $108,445	-5,425 Reduced 8.25%	60,364 $993,000
Q2 2023 Aug 09, 2023	SELL	$17.23 - $21.71 $628,447 - $791,850	-36,474 Reduced 35.67%	65,789 $1.32 Million
Q1 2023 Apr 20, 2023	SELL	$18.08 - $24.55 $54,456 - $73,944	-3,012 Reduced 2.86%	102,263 $1.93 Million
Q4 2022 Jan 12, 2023	BUY	$20.4 - $24.73 $232,437 - $281,773	11,394 Added 12.14%	105,275 $2.39 Million
Q3 2022 Nov 14, 2022	BUY	$22.29 - $35.04 $97,786 - $153,720	4,387 Added 4.9%	93,881 $2.48 Million
Q2 2022 Jul 19, 2022	BUY	$19.35 - $35.04 $415,773 - $752,904	21,487 Added 31.6%	89,494 $2.21 Million
Q1 2022 Apr 26, 2022	BUY	$24.62 - $34.31 $351,081 - $489,260	14,260 Added 26.53%	68,007 $2.26 Million
Q4 2021 Feb 14, 2022	BUY	$30.19 - $40.28 $690,113 - $920,760	22,859 Added 74.01%	53,747 $1.76 Million
Q3 2021 Nov 12, 2021	BUY	$29.09 - $45.68 $307,655 - $483,111	10,576 Added 52.07%	30,888 $1.3 Million
Q2 2021 Aug 13, 2021	BUY	$32.46 - $40.48 $659,327 - $822,229	20,312 New	20,312 $789,000

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $439M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.

Account

Hennion & Walsh Asset Management, Inc. Regenxbio Inc. Transaction History